Half-life determination of $^{155}$Tb from mass-separated samples produced at CERN-MEDICIS

Terbium-155 has been identified for its potential for single-photon emission computed tomography (SPECT) in nuclear medicine. For activity measurements, an accurate and precise half-life of this radionuclide is required. However, the currently evaluated half-life of 5.32(6) d with a relative standar...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, S M, Robinson, A P, Ivanov, P, Köster, U, Cocolios, T E, Russell, B, Webster, B, Fenwick, A J, Duchemin, C, Ramos, J P, Chevallay, E, Jakobsson, U, Stegemann, S, Regan, P H, Stora, T
Lenguaje:eng
Publicado: 2022
Acceso en línea:https://dx.doi.org/10.1016/j.apradiso.2022.110480
http://cds.cern.ch/record/2837180

Internet

https://dx.doi.org/10.1016/j.apradiso.2022.110480
http://cds.cern.ch/record/2837180

Ejemplares similares